RSS   Newsletter   Contact   Advertise with us

Cerulean Pharma promotes Scott Eliasof to senior vice president

Staff Writer | Cambridge, Mass., USA | October 28, 2016
Cerulean PharmaOctober 28, 2016, Cambridge, Mass., USA - Cerulean Pharma, a clinical stage company, announced that Scott Eliasof has been promoted to the role of senior vice president and chief scientific officer.
Before joining Cerulean in 2007, Dr. Eliasof was the director of the Chemical Biology Platform at the Broad Institute, directing a multi-disciplinary team of professional scientists and technicians in the fields of synthetic chemistry, analytical chemistry, high-throughput screening, computational science, and software engineering.

Prior to joining the Broad Institute, Dr. Eliasof worked at Millennium Pharmaceuticals, where he managed scientific teams in cellular biology, molecular biology, neuroscience, and bioinformatics for a large-scale genomics-based drug discovery program.

Earlier in his career, Dr. Eliasof was at Neurocrine Biosciences, where he played a key role in the exploration of glutamate transporters in the field of stroke and neurological disorders.

Dr. Eliasof earned his B.S. from MIT in electrical engineering, Ph.D. from the University of California at Berkeley in neuroscience, and completed his post-doctoral fellowship at the Vollum Institute in Portland, Oregon.

 LATEST MOVES FROM Massachusetts